Champions Oncology, Inc.
CSBR
$6.80
-$0.02-0.29%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.00M | 12.36M | 17.04M | 13.49M | 14.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.00M | 12.36M | 17.04M | 13.49M | 14.06M |
| Cost of Revenue | 8.00M | 7.27M | 6.62M | 7.43M | 7.07M |
| Gross Profit | 6.00M | 5.08M | 10.42M | 6.06M | 6.99M |
| SG&A Expenses | 4.43M | 4.84M | 4.20M | 3.64M | 4.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.50M | 14.07M | 12.54M | 12.76M | 12.73M |
| Operating Income | -507.00K | -1.71M | 4.50M | 732.00K | 1.33M |
| Income Before Tax | -452.00K | -1.96M | 4.52M | 739.00K | 1.33M |
| Income Tax Expenses | 14.00K | -129.00K | 23.00K | 11.00K | 21.00K |
| Earnings from Continuing Operations | -466.00K | -1.84M | 4.50M | 728.00K | 1.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 30.00K | -- | -- | -- | -- |
| Net Income | -436.00K | -1.84M | 4.50M | 728.00K | 1.31M |
| EBIT | -507.00K | -1.71M | 4.50M | 732.00K | 1.33M |
| EBITDA | -149.00K | -1.32M | 4.90M | 1.13M | 1.78M |
| EPS Basic | -0.03 | -0.13 | 0.33 | 0.05 | 0.10 |
| Normalized Basic EPS | -0.02 | -0.08 | 0.21 | 0.03 | 0.06 |
| EPS Diluted | -0.03 | -0.13 | 0.31 | 0.05 | 0.09 |
| Normalized Diluted EPS | -0.02 | -0.08 | 0.20 | 0.03 | 0.06 |
| Average Basic Shares Outstanding | 13.79M | 13.75M | 13.70M | 13.59M | 13.59M |
| Average Diluted Shares Outstanding | 13.79M | 13.75M | 14.36M | 14.02M | 14.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |